Logo

LAM IvyGene Test

May 30, 2018

Laboratory for Advanced Medicine has launched its non-invasive, epigenetics-based, laboratory-developed IvyGene test. IvyGene is designed to detect DNA methylation patterns consistent with the presence of cancer and provide quantitative data about the presence of cancer at the time of testing. It is intended to be used in conjunction with other diagnostic and confirmatory tests, including mammograms, PET scans and biopsies. To date, LAM said that the assay has been validated to detect four cancers: breast, colon, liver and lung, though the company has not yet published clinical validation results. 

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.